Correlation Between Pharmaceuticals Portfolio and Pharmaceuticals Ultrasector

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Pharmaceuticals Portfolio and Pharmaceuticals Ultrasector at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Pharmaceuticals Portfolio and Pharmaceuticals Ultrasector into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Pharmaceuticals Portfolio Pharmaceuticals and Pharmaceuticals Ultrasector Profund, you can compare the effects of market volatilities on Pharmaceuticals Portfolio and Pharmaceuticals Ultrasector and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Pharmaceuticals Portfolio with a short position of Pharmaceuticals Ultrasector. Check out your portfolio center. Please also check ongoing floating volatility patterns of Pharmaceuticals Portfolio and Pharmaceuticals Ultrasector.

Diversification Opportunities for Pharmaceuticals Portfolio and Pharmaceuticals Ultrasector

0.92
  Correlation Coefficient

Almost no diversification

The 3 months correlation between PHARMACEUTICALS and Pharmaceuticals is 0.92. Overlapping area represents the amount of risk that can be diversified away by holding Pharmaceuticals Portfolio Phar and Pharmaceuticals Ultrasector Pr in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Pharmaceuticals Ultrasector and Pharmaceuticals Portfolio is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Pharmaceuticals Portfolio Pharmaceuticals are associated (or correlated) with Pharmaceuticals Ultrasector. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Pharmaceuticals Ultrasector has no effect on the direction of Pharmaceuticals Portfolio i.e., Pharmaceuticals Portfolio and Pharmaceuticals Ultrasector go up and down completely randomly.

Pair Corralation between Pharmaceuticals Portfolio and Pharmaceuticals Ultrasector

Assuming the 90 days horizon Pharmaceuticals Portfolio is expected to generate 2.56 times less return on investment than Pharmaceuticals Ultrasector. But when comparing it to its historical volatility, Pharmaceuticals Portfolio Pharmaceuticals is 1.7 times less risky than Pharmaceuticals Ultrasector. It trades about 0.08 of its potential returns per unit of risk. Pharmaceuticals Ultrasector Profund is currently generating about 0.12 of returns per unit of risk over similar time horizon. If you would invest  1,843  in Pharmaceuticals Ultrasector Profund on April 22, 2025 and sell it today you would earn a total of  70.00  from holding Pharmaceuticals Ultrasector Profund or generate 3.8% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthVery Strong
Accuracy100.0%
ValuesDaily Returns

Pharmaceuticals Portfolio Phar  vs.  Pharmaceuticals Ultrasector Pr

 Performance 
       Timeline  
Pharmaceuticals Portfolio 

Risk-Adjusted Performance

Modest

 
Weak
 
Strong
Compared to the overall equity markets, risk-adjusted returns on investments in Pharmaceuticals Portfolio Pharmaceuticals are ranked lower than 6 (%) of all funds and portfolios of funds over the last 90 days. In spite of fairly weak basic indicators, Pharmaceuticals Portfolio may actually be approaching a critical reversion point that can send shares even higher in August 2025.
Pharmaceuticals Ultrasector 

Risk-Adjusted Performance

OK

 
Weak
 
Strong
Compared to the overall equity markets, risk-adjusted returns on investments in Pharmaceuticals Ultrasector Profund are ranked lower than 7 (%) of all funds and portfolios of funds over the last 90 days. In spite of fairly weak basic indicators, Pharmaceuticals Ultrasector may actually be approaching a critical reversion point that can send shares even higher in August 2025.

Pharmaceuticals Portfolio and Pharmaceuticals Ultrasector Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Pharmaceuticals Portfolio and Pharmaceuticals Ultrasector

The main advantage of trading using opposite Pharmaceuticals Portfolio and Pharmaceuticals Ultrasector positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Pharmaceuticals Portfolio position performs unexpectedly, Pharmaceuticals Ultrasector can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Pharmaceuticals Ultrasector will offset losses from the drop in Pharmaceuticals Ultrasector's long position.
The idea behind Pharmaceuticals Portfolio Pharmaceuticals and Pharmaceuticals Ultrasector Profund pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Suggestion module to get suggestions outside of your existing asset allocation including your own model portfolios.

Other Complementary Tools

Portfolio Analyzer
Portfolio analysis module that provides access to portfolio diagnostics and optimization engine
Portfolio Center
All portfolio management and optimization tools to improve performance of your portfolios
Fundamental Analysis
View fundamental data based on most recent published financial statements
Positions Ratings
Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance
Portfolio Volatility
Check portfolio volatility and analyze historical return density to properly model market risk